Optimal cut-offs for down syndrome contingent screening in a population of 10 156 pregnant women

被引:10
|
作者
Guanciali-Franchi, Paolo [1 ,2 ]
Iezzi, Irene [1 ,2 ]
Soranno, Alessandra [1 ,2 ]
de Volo, Chiara Palka-Bayard [3 ]
Alfonsi, Melissa [1 ,2 ]
Calabrese, Giuseppe [1 ,2 ]
Benn, Peter [4 ]
机构
[1] Spirito Santo Hosp, Dept Med Genet, Pescara, Italy
[2] Univ G DAnnunzio, Dept Med Genet, Chieti, Italy
[3] Univ G DAnnunzio, Dept Pediat, Chieti, Italy
[4] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA
关键词
RISK; 1ST; 1ST-TRIMESTER; PARAMETERS; TRIMESTER; SERUM;
D O I
10.1002/pd.3974
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Study design A population of 10?156 pregnant women with singleton pregnancies were screened by the integrated test. Risks were retrospectively recalculated for contingent test strategies with first step intermediate risk groups defined by first trimester upper cut-offs of 1?:?10, 1?:?30, 1?:?50, and 1?:?70 and lower cut-offs 1?:?1500, 1?:?1200, 1?:?1100, and 1?:?900. The second trimester high risk group was based on a single cut-off of 1?:?250. Results In the first trimester, the detection rate (DR) ranged from 21% (6/29) to 52% (15/29) as the high risk first trimester cut-off was changed from 1?:?10 to 1?:?70. The corresponding first trimester false positive rate (FPR) increased from 0.2% to 1.4%. In the second trimester, an additional 21/29 (72%) to 12/29 (41%) affected pregnancies could be detected with an additional 1.6% to 2.7% false positives when lower first trimester cut-offs of 1?:?900 to 1?:?1500 were used. The best results were obtained with the upper first trimester cut-off of 1?:?30 and lower first trimester cut-off of 1?:?900, which yielded a rate of women requiring a second trimester test of only 12%, with overall DR and FPR of 93% and 2.8%, respectively. Conclusions Although the study population was relatively small, the results confirm the advantage of using contingent screening and suggest optimal first trimester cut-offs of 1?:?30 (lower cut-off) and 1?:?900 (upper cut-off). (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:1147 / 1150
页数:4
相关论文
共 50 条
  • [31] Does Screening for Down's Syndrome Cause Anxiety in Pregnant Women? A Systematic Review
    Lou, Stina
    Mikkelsen, Line
    Hvidman, Lone
    Peterson, Olav B.
    Nielsen, Camila Palmhoj
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (05) : 309 - 310
  • [32] Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population
    Xie, Zhenwei
    Lu, Shiming
    Li, Hui
    PRENATAL DIAGNOSIS, 2010, 30 (01) : 74 - 76
  • [33] Fragile X syndrome carrier screening in pregnant women in Chinese Han population
    Chia-Cheng Hung
    Chien-Nan Lee
    Yu-Chu Wang
    Chih-Ling Chen
    Tze-Kang Lin
    Yi-Ning Su
    Ming-Wei Lin
    Jessica Kang
    Yi-Yun Tai
    Wen-Wei Hsu
    Shin-Yu Lin
    Scientific Reports, 9
  • [34] Fragile X syndrome carrier screening in pregnant women in Chinese Han population
    Hung, Chia-Cheng
    Lee, Chien-Nan
    Wang, Yu-Chu
    Chen, Chih-Ling
    Lin, Tze-Kang
    Su, Yi-Ning
    Lin, Ming-Wei
    Kang, Jessica
    Tai, Yi-Yun
    Hsu, Wen-Wei
    Lin, Shin-Yu
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri, Eunate
    Idigoras, Isabel
    Uranga, Begona
    Perez, Raquel
    Irurzun, Ana
    Gutierrez-Ibarluzea, Inaki
    Fraser, Callum G.
    Portillo, Isabel
    BMC CANCER, 2017, 17
  • [36] Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Eunate Arana-Arri
    Isabel Idigoras
    Begoña Uranga
    Raquel Pérez
    Ana Irurzun
    Iñaki Gutiérrez-Ibarluzea
    Callum G. Fraser
    Isabel Portillo
    BMC Cancer, 17
  • [37] GC-MS analysis of seven metabolites for the screening of pregnant women with Down Syndrome fetuses
    Ozkan, Ece
    Nemutlu, Emirhan
    Beksac, Mehmet Sinan
    Kir, Sedef
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 188
  • [38] The Effect of Inhibin A on Prenatal Screening Results for Down Syndrome in the High Risk Czech Pregnant Women
    Loucky, Jaroslav
    Belaskova, Silvie
    Prusa, Richard
    Kotaska, Karel
    CLINICAL LABORATORY, 2019, 65 (05) : 707 - 716
  • [39] Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age
    Cavalli, P
    Gnocchi, E
    Pennacchio, A
    Morrica, B
    PRENATAL DIAGNOSIS, 1998, 18 (06) : 637 - 638
  • [40] Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results
    Brajenovic-Milic, Bojana
    Babic, Ivana
    Ristic, Smiljana
    Vranekovic, Jadranka
    Brumini, Gordana
    Kapovic, Milienko
    WOMENS HEALTH ISSUES, 2008, 18 (02) : 79 - 84